Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD)

Journal of Psychosomatic Research

Volumn 72, Issue 1, 2012, Pages 11-16

  Hansen, Baiba Hedegaard ^a   Hanash, Jamal Abed ^a   Rasmussen, Alice ^a   Hansen, JØrgen Fischer ^a   Andersen, Nadia Lyhne Trørup ^a   Nielsen, Olav Wendelboe ^a   Birket Smith, Morten ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Acute coronary syndrome; Depression; Escitalopram; Prevention

Indexed keywords

ESCITALOPRAM; PLACEBO;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVAL; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT;

ACUTE CORONARY SYNDROME; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84455191862     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.07.001     Document Type: Article

References (44)

1. Rugulies R Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002, 23:51-61.
2. Nicholson A, Kuper H, Hemingway H Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
3. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006, 21:30-38.
4. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822.
5. Barth J, Schumacher M, Herrmann-Lingen C Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004, 66:802-813.
6. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116.
7. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
8. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AM, Crijns HJ, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007, 190:460-466.
9. Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, Van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
10. Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sorensen HT Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med 2004, 117:732-737.
11. Schlienger RG, Fischer LM, Jick H, Meier CR Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 2004, 27:1157-1165.
12. Sauer WH, Berlin JA, Kimmel SE Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003, 108:32-36.
13. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003, 163:59-64.
14. Layton D, Clark DW, Pearce GL, Shakir SA Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001, 57:167-176.
15. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004, 164:2367-2370.
16. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?. Aliment Pharmacol Ther 2005, 22:175-181.
17. Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, Mahaffey KW, et al. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 2006, 98:42-47.
18. Tata LJ, West J, Smith C, Farrington P, Card T, Smeeth L, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005, 91:465-471.
19. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008, 300:2161-2171.
20. Pizzi C, Rutjes AW, Costa GM, Fontana F, Mezzetti A, Manzoli L Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 2011, 107:972-979.
21. Diez-Quevedo C, Masnou H, Planas R, Castellvi P, Gimenez D, Morillas RM, et al. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2011, 72:522-528.
22. Chen Y, Patel NC, Guo JJ, Zhan S Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol 2007, 22:159-166.
23. Hansen BH, Hanash JA, Rasmussen A, Hansen JF, Birket-Smith M Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of depression in acute coronary syndrome (DECARD). Trials 2009, 10:20.
24. Alpert JS, Thygesen K, Antman E, Bassand JP Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
25. Bech P, et al. Scales of assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand Suppl 1993, 87:3-83. Ref Type: Report.
26. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987, 334:1-100.
27. Schedules for clinical assessment in neuropsychiatry, Version 2.1. Århus 2000.
28. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
29. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. Am Heart J 2000, 139:1-9.
30. Lesperance F, Frasure-Smith N, Talajic M Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996, 58:99-110.
31. Konsensusrapport. Akut koronart syndrom. Retningslinjer for diagnostik og behandling. KØbenhavn, Dansk Cardiologisk Selskab. Ref Type: Report 2004.
32. Huffman JC, Smith FA, Blais MA, Taylor AM, Januzzi JL, Fricchione GL Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction. Psychosomatics 2008, 49:309-316.
33. Murdoch D, Keam SJ Escitalopram: a review of its use in the management of major depressive disorder. Drugs 2005, 65:2379-2404.
34. Narushima K, Kosier JT, Robinson RG Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002, 190:296-303.
35. de Jonge P, van den Brink RH, Spijkerman TA, Ormel J Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol 2006, 48:2204-2208.
36. Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005, 96:1179-1185.
37. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
38. Parker GB, Hilton TM, Walsh WF, Owen CA, Heruc GA, Olley A, et al. Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol Psychiatry 2008, 64:660-666.
39. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008, 299:2391-2400.
40. Irvine J, Basinski A, Baker B, Jandciu S, Paquette M, Cairns J, et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999, 61:729-737.
41. Lesperance F, Frasure-Smith N, Juneau M, Theroux P Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000, 160:1354-1360.
42. Moldrup C, Knudsen P, Traulsen JM The term happiness pill is a problematic Danish phenomenon. Ugeskr Laeger 2005, 167:2282-2285.
43. Rasmussen A, Lunde M, Poulsen DL, Sorensen K, Qvitzau S, Bech P A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003, 44:216-221.
44. Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.